Tolcapone (Corino Therapeutics/SOM Biotech)

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameTolcapone (Corino Therapeutics/SOM Biotech)
Drug Alias NameCRX-1008SOM 0226
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatechol-O-methyl transferase inhibitors
TargetsCatechol-O-methyl transferase
Therapy Area/IndicationsTransthyretin amyloidosisAmyloid Neuropathies, FamilialNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomSpain
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSom Innovation Biotech SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSom Innovation Biotech SACorino Therapeutics IncBoston University
Active IndicationsN/A
Inactive IndicationsTransthyretin amyloidosisAmyloid Neuropathies, FamilialNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A